AIP
JNJ icon

Arrowpoint Investment Partners’s Johnson & Johnson JNJ Stock Holding History

Arrowpoint Investment Partners’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.93M Sell
7,902
-306,027
-97% -$71.3M 1.72% 15
2025
Q4 		$65M Buy
+313,929
New +$62.1M 9.57% 3

Other funds holding JNJ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Arrowpoint Investment Partners's JNJ Position: Q1 2026 in Review

Arrowpoint Investment Partners reduced its Johnson & Johnson (JNJ) stake by 97% in Q1 2026, selling an estimated $71.3M and leaving 7,902 shares worth $1.93M. The position accounts for 1.72% of the portfolio, ranked #15.

Arrowpoint Investment Partners first reported a position in JNJ in Q4 2025 and has held it in 2 quarters since. The position peaked at $65M in Q4 2025. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Arrowpoint Investment Partners held 7,902 shares of Johnson & Johnson worth $1.93M as of Q1 2026.
  • Arrowpoint Investment Partners sold 306,027 Johnson & Johnson shares in Q1 2026, an estimated $71.3M.
  • Johnson & Johnson made up 1.72% of Arrowpoint Investment Partners's portfolio in Q1 2026, its #15 holding.
  • Arrowpoint Investment Partners first reported a position in Johnson & Johnson in Q4 2025 and has held it in 2 quarters since.
  • Arrowpoint Investment Partners's Johnson & Johnson position peaked at $65M in Q4 2025.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Arrowpoint Investment Partners's 13F filing for Q1 2026, filed 14 May 2026.